SCOTT SCHLACKMAN - 09 May 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves attorney-in-fact
Issuer symbol
MED
Transactions as of
09 May 2023
Net transactions value
+$1,150
Form type
4
Filing time
11 May 2023, 17:41:28 UTC
Previous filing
14 Mar 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Purchase $1,150 +13 +0.18% $87.50 7,293 09 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.